WeVote

Bill

Bill

HB 2560

Modifies provisions relating to epinephrine delivery devices

2026 Regular Session Introduced by George Hruza and 1 co-sponsor

HB 2560 modifies epinephrine auto-injector regulations in Missouri, advancing through committee with a do-pass recommendation to address accessibility or liability concerns.

HCS Reported Do Pass (H)
0
WeVote Research Nonpartisan
Bill Summary · HB 2560

Legislative bill overview

HB 2560 modifies Missouri's regulations governing epinephrine auto-injectors (EpiPens), likely addressing accessibility, liability, storage, or prescription requirements for these emergency medical devices. The bill has advanced through committee with a "do pass" recommendation as of February 2026.

Why is this important

Epinephrine auto-injectors are life-saving devices used during severe allergic reactions and anaphylaxis. Modifications to how they're delivered, stored, or distributed can directly impact whether people in emergency situations can access treatment quickly enough to prevent death or serious injury.

Potential points of contention

  • Liability protections: Whether the bill expands or limits legal immunity for schools, workplaces, or bystanders who administer epinephrine without specific medical training
  • Prescription vs. over-the-counter access: Whether modifications make devices more accessible without prescriptions or maintain stricter dispensing controls
  • Stock epinephrine programs: Disagreement over whether public facilities should maintain emergency supplies and who bears the cost of expired/unused devices

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.